Clinical Trials in Phoenix

Showing 3161-3180 of 16,646 trials

XG005 for Pain Control in Subjects Undergoing Bunionectomy

NCT06017999

This study will evaluate the safety, efficacy, and PK of low dose (750 mg) and high-dose (1250 mg) XG005 oral tablets compared with placebo in subjects undergoing bunionectomy. Subjects will be confined in the clinic from check-in through 72 hours post-surgery to monitor subject safety.

Acute Pain

Xgene Pharmaceutical Group450 participantsStarted Aug 2023

Phoenix, Arizona, United States • San Diego, California, United States • Hialeah, Florida, United States +5 more locations

RECRUITINGPhase 3< 1 mile

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

NCT06499857

The goal of the study is to learn how a weight loss medication called semaglutide, which is used to treat obesity, in addition to standard AF treatment might affect AF, atrial fibrillation severity, and whether it changes the risk of atrial fibrillation recurring after standard AF treatments.

Overweight or ObesityAtrial Fibrillation

University of Chicago200 participantsStarted Apr 2025

Phoenix, Arizona, United States • Chicago, Illinois, United States

RECRUITINGPhase 3< 1 mile

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

NCT06470451

To evaluate the use of HyBryte, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).

CTCL/ Mycosis FungoidesCTCLMycosis Fungoides+1 more

Soligenix80 participantsStarted Jan 2025

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • San Diego, California, United States +14 more locations

XG005 for Pain Control in Subjects Undergoing Bunionectomy

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Find Trials by Condition in Phoenix

A Study to Assess Growth in Children With Idiopathic Short Stature

A Trial Evaluating TG4050 in Ovarian Carcinoma.

M6-C Artificial Cervical Disc Two-Level IDE Pivotal Study

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

A Study of PF-06873600 in People With Cancer

A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

Comparison of Two Pulmonary Embolism Treatments

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma

Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Safety Study of PP-007 in Subjects With Acute Ischemic Stroke

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)